Repurposing approved drugs as potential efflux pump inhibitors in multidrug-resistant <i>Pseudomonas aeruginosa</i>-Reference-Cited by-同舟云学术

Repurposing approved drugs as potential efflux pump inhibitors in multidrug-resistant Pseudomonas aeruginosa

Published:2024-04-12 Issue:6 Volume:19 Page:495-508
ISSN:1746-0913
Container-title:Future Microbiology
language:en
Short-container-title:Future Microbiology

Author:

de Melo Guedes Gláucia Morgana¹²^ORCID,Pereira Vinicius Carvalho¹^ORCID,Freitas Alyne Soares¹^ORCID,Honório de Souza Paulo Roberto¹^ORCID,Chacon Parra Aura Lucia¹^ORCID,Brasil Jaiane Alves¹^ORCID,de Medeiros Guedes Rodrigo Fonseca¹^ORCID,Pereira de Sousa Paulo César³^ORCID,Aguiar Cordeiro Rossana de²^ORCID,Gadelha Rocha Marcos Fábio²⁴^ORCID,Costa Sidrim José Júlio²^ORCID,Souza Collares Maia Castelo Branco Débora de¹²^ORCID

Affiliation:

1. Department of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Group of Applied Medical Microbiology, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil

2. Department of Pathology and Legal Medicine, Postgraduate Program in Medical Microbiology, Laboratory of Emerging and Reemerging Pathogens, Federal University of Ceará, Fortaleza, Ceará, 60430-275, Brazil

3. Walter Cantídio University Hospital, Federal University of Ceará, Fortaleza, Ceará, 60430-372, Brazil

4. Postgraduate Program in Veterinary Sciences, School of Veterinary, State University of Ceará, Fortaleza, Ceará, 60714-903, Brazil

Funder

Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/fmb-2023-0208

Reference37 articles.

1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

2. Updates on the pathogenicity status of Pseudomonas aeruginosa

3. Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections

4. Antibacterial-Resistant Pseudomonas aeruginosa : Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms

5. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses